|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MMP-9 (Matrix Metalloproteinase-9)
Test Code36408
CPT Codes
83520<br>Restricted Client Code
Preferred Specimen
1 mL frozen serum collected in a gel-barrier tube
Minimum Volume
0.5 mL
Instructions
Transfer serum to a plastic transport tube before freezing. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit frozen specimen for each test requested.
Transport Temperature
Frozen
Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 60 days
Refrigerated: Unacceptable
Frozen: 60 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature • Received refrigrated
Methodology
Enzyme-Linked Immunosorbent Assay (ELISA)
FDA Status
The performance characteristics of this assay have not been established. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.
Setup Schedule
Set up: Mon-Sun; Report available: 3-7 days
Reference Range
<984 ng/mL
Clinical Significance
MMP-9 is a marker of inflammation, tissue remodeling, wound healing, and mobilization of tissue-bound growth factors and cytokines. Its expression correlates with abnormal collagen deposition accompanying pancreatic cancer, with lymph node metastasis in breast cancer and with regional vessel invasion by giant cell tumor or bone. MMP-9 contributes to the pathogenesis of numerous clinical disease states, including rheumatic arthritis, coronary artery disease, chronic obstructive pulmonary disease, multiple sclerosis, asthma, and cancer. Current research is exploring the role of this enzyme as a potential drug target.

